Program Overview

ON-DEMAND VIDEO/ENDURING PROGRAM AVAILABLE ONLINE THRU APRIL 27, 2024

Learning Objectives
-Discuss the prevalence and pathogenesis of cardiorenal complications.
-Discuss current guidelines for optimal management of diabetic patients to prevent and treat cardiorenal complications.
-Discuss the mechanism of action and indications/contraindications of GLP1-agonists and SGLT2-inhibitors.

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.

Physicians (ACCME) Credit Designation Statement

Amedco LLC designates this live virtual activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 



Physician Assistants

PAs may claim a maximum of 4.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioners

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum of 4.0 hours.